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Abstract
Background: Invasive methods requiring general anaesthesia are needed to sample the lung microbiota in young
children who do not expectorate. This poses substantial challenges to longitudinal study of paediatric airway
microbiota. Non-invasive upper airway sampling is an alternative method for monitoring airway microbiota;
however, there are limited data describing the relationship of such results with lung microbiota in young children.
In this study, we compared the upper and lower airway microbiota in young children to determine whether
non-invasive upper airway sampling procedures provide a reliable measure of either lung microbiota or clinically
defined differences.
Results: The microbiota in oropharyngeal (OP) swabs, nasopharyngeal (NP) swabs and bronchoalveolar lavage (BAL)
from 78 children (median age 2.2 years) with and without lung disease were characterised using 16S rRNA gene
sequencing. Permutational multivariate analysis of variance (PERMANOVA) detected significant differences between
the microbiota in BAL and those in both OP swabs (p = 0.0001, Pseudo-F = 12.2, df = 1) and NP swabs (p = 0.0001;
Pseudo-F = 21.9, df = 1) with the NP and BAL microbiota more different than the OP and BAL, as indicated by a
higher Pseudo-F value. The microbiota in combined OP and NP data (upper airways) provided a more
comprehensive representation of BAL microbiota, but significant differences between the upper airway and BAL
microbiota remained, albeit with a considerably smaller Pseudo-F (PERMANOVA p = 0.0001; Pseudo-F = 4.9, df = 1).
Despite this overall difference, paired BAL and upper airway (OP and NP) microbiota were >50 % similar among
69 % of children. Furthermore, canonical analysis of principal coordinates (CAP analysis) detected significant
differences between the microbiota from clinically defined groups when analysing either BAL (eigenvalues >0.8;
misclassification rate 26.5 %) or the combined OP and NP data (eigenvalues >0.8; misclassification rate 12.2 %).
Conclusions: Upper airway sampling provided an imperfect, but reliable, representation of the BAL microbiota for
most children in this study. We recommend inclusion of both OP and NP specimens when non-invasive upper
airway sampling is needed to assess airway microbiota in young children who do not expectorate. The results of
the CAP analysis suggest lower and upper airway microbiota profiles may differentiate children with chronic
suppurative lung disease from those with persistent bacterial bronchitis; however, further research is needed to
confirm this observation.
Keywords: Paediatric lung disease, Upper airways, Lower airways, Oropharynx, Nasopharynx, Bronchoalveolar
lavage, Microbiota
* Correspondence: robyn.marsh@menzies.edu.au
1Menzies School of Health Research, Charles Darwin University, PO Box
41096, Casuarina, Darwin, NT 0810, Australia
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Marsh et al. Microbiome  (2016) 4:37 
DOI 10.1186/s40168-016-0182-1
Background
In recent years, molecular methods have clearly demon-
strated that the lungs are not sterile at homeostasis.
Adult studies have shown that microaspiration of the
upper respiratory secretions continually inoculates the
lungs with oral microbiota [1]; host defences must then
efficiently clear or contain the microbes to prevent infec-
tion [2]. Changes in the lower airway microbiota during
the onset and progression of acute and chronic lung dis-
eases are poorly understood.
In adults and older children, spontaneous and induced
sputum are used non-invasively to sample the lower air-
ways for assessment of the lung microbiota. Studies in
very young children who do not expectorate are more
challenging as invasive procedures, such as bronchoalve-
olar lavage (BAL) collected via bronchoscopy, are re-
quired to sample the lower airway microbiota [3]. The
invasive nature of BAL, including a requirement for gen-
eral anaesthesia, renders it neither suitable nor ethically
feasible for longitudinal studies [4]. Reflecting this limi-
tation, studies of lung microbiota in very young children
have generally been cross-sectional [5].
Upper airway sampling has long been considered an
alternative method for assessing airway microbiology in
young children [6] but remains controversial as signifi-
cant differences between the upper and lower airway
microbiota have been detected in several studies [7–11].
In recent years, studies comparing upper and lower air-
way specimens have reported that the lower airway
microbiota is more similar to that of the oropharynx
than that in the nose or nasopharynx [1, 12, 13]; how-
ever, these studies have been limited to adults [1, 12]
and older children (>7 years) [13]. It is unclear if these
data can be extrapolated to other paediatric populations,
especially as the nasopharynx is an important reservoir
of lower respiratory pathogens in young children [14, 15].
Numerous studies have highlighted the importance of the
nasopharyngeal (NP) microbiota, particularly pathogenic
species, to lung disease in infants and young children
[16–21]. Furthermore, culture-based studies have dem-
onstrated that oropharyngeal (OP) swabs do not reli-
ably predict the presence of respiratory pathogens in
the lower airways of children <2 years of age [6].
In this study, we have directly compared OP, NP and
BAL microbiota in young children. Our study included
78 children who had protracted bacterial bronchitis
(PBB), chronic suppurative lung disease (CSLD) or no
lung disease (controls). We aimed to determine (i) the
similarity of the microbiota in the OP and NP compared
to BAL and (ii) whether non-invasive sampling of the
upper airways provided a reliable measure of either the
lung microbiota or differences between clinically defined
groups. We hypothesised that the BAL microbiota in
young children would show similarity to both the OP
and NP microbiota.
Results
The study cohort (Table 1) included 78 children—40
children with CSLD, including 36 with idiopathic bron-
chiectasis confirmed by chest high-resolution computed
Table 1 Study cohort
Controls PBB CSLD
Number of children 10 28 40 (36 with BE)
Region
Brisbane 10 28 5 (all with BE)
Darwin 0 0 35 (31 with BE)
Median age in years (95 % CI) 2.0 (1.0–4.0) 1.8 (1.4–2.3) 2.6 (2.1–3.1)
Number of Indigenous children (%) 0 (0) 2 (7) 33 (83)
Males (%) 8 (80) 16 (57) 23 (58)
Received antibiotics within 2 weeks of bronchoscopy (%) 2 (20) 6 (21) 26 (65)
Azithromycin 1 1 17
Amoxicillin 0 0 1
Amoxicillin clavulanate 1 3 1
Sulfamethoxazole trimethoprim 0 2 1
Roxithromycin 0 0 1
Ceftriaxone 0 0 2
Azithromycin + sulphamethoxazole trimethoprim 0 0 1
Ceftriaxone, amoxicillin clavulanate, flucloxicillin 0 0 1
Unsure if received antibiotics 0 0 1
BE idiopathic bronchiectasis
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tomography (cHRCT), 28 with PBB and 10 controls.
The median age of the children in the three groups were
similar (median 2.2 years; Kruskal-Wallis p = 0.19,
Table 1). Twenty percent of the control children, 21 %
of the children with PBB and 65 % of the children with
CSLD had recently received antibiotics (defined as anti-
biotic treatment within 2 weeks of bronchoscopy).
Eighty-three percent of children with CSLD, 7 % of chil-
dren with PBB and none of the controls were Indigenous
Australians (Table 1).
An OP swab, NP swab and two sequential BAL speci-
mens (Lavage-1 and Lavage-2) were available for 68
children (36 with CSLD, 22 with PBB and 10 control
children). For the remaining 10 children, only the OP
swab, NP swab and Lavage-1 were available. Thus, 302
specimens from 78 children were available for testing
(Fig. 1).
DNA extracts from a high proportion of clinical
specimens reflected low bacterial load
The bacterial load in each DNA extract was estimated
by qPCR [22, 23]. A level of >103 genome equivalents
(GE)/μL extracted DNA is recommended for 16S
rRNA gene sequencing [24, 25]. This threshold was
met by 207/302 (68 %) specimens. Bacterial load could
not be estimated for one Lavage-1 sample due to the
presence of PCR inhibitors. Low bacterial load (defined
here as <103 GE/μL extracted DNA) was detected for
33/78 (42 %) NP swabs, 1/78 (1.3 %) OP swabs, 29/77
(38 %) Lavage-1 and 31/68 (46 %) Lavage-2 specimens
(Fig. 2); 44 of these specimens failed to amplify above
the qPCR limit of detection (90 GE), indicating very
low bacterial load or an absence of bacteria (15 NP
swabs, 1 OP swab, 11 Lavage-1 and 17 Lavage-2 speci-
mens; Fig. 2).
The data were then reviewed to determine if speci-
mens with low bacterial loads were provided by the
same or by different children. Overall, low bacterial load
was detected in at least one specimen from 49/78 (63 %)
children. Approximately half of these children (49 %)
had recently received antibiotics, a proportion similar to
the antibiotic exposure rate for all subjects (43 %), sug-
gesting that low bacterial load was unrelated to recent
antibiotic exposure. DNA extracts from all of the speci-
mens from one control child had low bacterial load;
this child had received amoxicillin clavulanate. A fur-
ther 14 children had low bacterial loads detected for
the NP swab, Lavage-1 and Lavage-2 specimens (4 con-
trol children, 1 child with PBB and 9 with CSLD); six of
these children had recently received antibiotics. Low
bacterial load was detected in the NP swabs from 17
children from whom the paired Lavage-1 specimens
contained >103 GE/μL extracted DNA. No children had
low bacterial load in the OP swab when the load in
paired Lavage-1 specimen was >103 GE/μL extracted
DNA. Bacterial load in any specimen type was unre-
lated to the age of the children (all Spearman rank cor-
relation p > 0.29).
16S rRNA gene sequencing was successful for most
specimens, including those with low bacterial load
Regardless of the bacterial load, all of the 302 specimens
were processed for 16S rRNA gene sequencing. One NP
swab, two Lavage-1 specimens and one Lavage-2 speci-
men failed to generate any 16S rRNA gene sequencing
Fig. 1 Summary of specimen processing after 16S rRNA gene sequencing. Specimens that returned <1025 reads were excluded from further analysis
as bacterial community coverage in these specimens (based on rarefaction and Good’s coverage) was too low
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data; each of these specimens also failed to amplify in
the bacterial load qPCR.
As a high proportion of the specimens had low bac-
terial load, the sequence data were reviewed for the
presence of probable contaminant taxa [24, 26], as de-
scribed in Additional file 1. Overall, 237 operational
taxonomic units (OTUs) consistent with 54 genera re-
ported previously as contaminants in DNA extraction
reagents [24, 26] were identified and removed prior to
downstream analyses (Additional file 1: Table S1). The
relative abundance of these OTUs ranged from 0 to
89 % (median 0.2 %) and showed a significant inverse cor-
relation with the bacterial load in the extracted DNA
(Spearman rho = −0.85; p < 0.0001). All specimens with
probable contaminant genera detected at relative abun-
dance >20 % had low bacterial load. There was no signifi-
cant difference in the relative abundance of the probable
contaminant OTUs in NP swabs, Lavage-1 or Lavage-2
specimens (Additional file 1: Figure S1). The relative
abundance of the probable contaminant OTUs did not ex-
ceed 20 % in any OP swab, reflecting the high proportion
of OP swabs (77/78) that had bacterial load >103 GE/μL
extracted DNA (Fig. 2).
After exclusion of probable contaminant OTUs, there
were 90–17,444 sequencing reads/specimen (median
4639). The data were subsampled to 1025 reads/speci-
men to achieve a balance between sufficient sampling
depth and exclusion of low-quality specimens. Good’s
coverage at this depth was >95 % for the 277 specimens
with >1025 reads. This included 77/94 (82 %) specimens
that had low bacterial load, 27 of which had failed to amp-
lify above the qPCR’s limit of detection. After removal of
the contaminant OTUs, low bacterial load specimens did
not cluster separately to specimens with >103 GE/μL
extracted DNA in principal coordinate analysis (PCoA;
Additional file 1: Figure S2).
Twenty-five specimens had <1025 reads and were ex-
cluded from further analysis (Fig. 1). This left 277 speci-
mens from 78 children. For 73 children, paired sequence
data were available from the upper and/or lower airway
specimens. Of these, 65/73 children had sequence data
for the OP swab, NP swab and Lavage-1 (8 controls, 19
with PBB and 38 with CSLD); 57/78 had data for
Lavage-1 and Lavage-2 (6 controls, 19 PBB and 32 with
CSLD); and 49 had data for all four specimen types (5
controls, 13 with PBB and 31 with CSLD). Five children
were excluded from analyses of paired data because
their NP swab and one or both lavage specimens
returned <1025 sequence reads (Fig. 1).
Alpha diversity in the OP, NP and lower airways
A total of 1954 OTUs were present in the subsampled
dataset, with 290 (14.8 %) OTUs present at >1 % relative
abundance. Bacterial richness ranged from 3 to 100
OTUs per specimen (Fig. 3a). Simpson’s index of diver-
sity ranged from 0.003 to 0.955 (Fig. 3b). Diversity by
Fig. 2 Bacterial load in DNA extracted from clinical specimens. Bacterial load is expressed on a log-scale as genome equivalents (GE)/μL
extracted DNA. The red dashed line indicates 1 × 103 GE/μL of the extracted DNA. The black dotted line indicates the qPCR limit of detection
(90 GE). Quantification below the qPCR limit of detection (90 GE) is unreliable. NP NP swab, OP OP swab
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Simpson’s index was significantly lower in NP swabs
compared to all other specimen types (all Dunn’s post
hoc test, p < 0.0001), reflecting the more common dom-
inance of individual OTUs in the NP microbiota (Fig. 3c).
Overall, 69.2 % of NP swabs, 1.3 % OP swabs, 25 %
Lavage-1 and 22 % Lavage-2 specimens were dominated
by a single OTU at >50 % relative abundance. Dominant
OTUs were consistent with taxa commonly detected in
airway specimens, including Moraxella, Haemophilus,
Staphylococcus, Streptococcus, Neisseria, Prevotella and
Corynebacterium species (Table 2).
Diversity in any specimen type was not significantly
associated with antibiotic treatment within 2 weeks of
bronchoscopy and was unrelated to bacterial load in OP
swab, NP swab and Lavage-2 specimens (all Mann-
Whitney U test p > 0.05). Diversity was significantly
higher in Lavage-1 specimens with low bacterial load
(median 0.89; 95 % CI 0.83–0.91) compared to those
with higher loads (median 0.79, 95 % CI 0.71–0.83;
Mann-Whitney U test p = 0.0005); however, this finding
is unlikely to indicate a systemic bias as it was not repro-
duced in analysis of other specimen types. Diversity in
any specimen type was unrelated to the age of the chil-
dren (all Spearman correlation p > 0.08).
Diversity in NP swabs increased with disease severity
(Fig. 3d); however, only the comparison of the control
and CSLD children showed significant differences after
correction for multiple measures (Dunn’s post hoc test,
p < 0.0001). There was no significant difference in the
microbiota diversity in the OP, Lavage-1 and Lavage-2
specimens from different diagnostic groups (Additional
file 1: Figure S3). There was no significant correlation
between the diversity in lavage specimens and that in
corresponding OP or NP swabs (all Spearman rank cor-
relation p > 0.07), reflecting differences in the relative
abundance of dominant OTUs in the upper and lower
airway data.
Comparison of OP and NP microbiota
Consistent with earlier studies [1, 12, 13, 25], the OP
and NP microbiota were distinct. Median Bray-Curtis
similarity between paired OP and NP swabs was only
10.1 % (95 % CI 8.2–12.6). In a PCoA (Fig. 4a), OP and
NP data points were well separated across the first axis
(PCO1), which explained 19.6 % of the total data vari-
ability. Separation across PCO1 also reflected differences
in the relative abundance of the dominant OTU in each
specimen (Fig. 4b). A vector plot showing directional ef-
fects for the most dominant OTUs was consistent with
separation of OP and NP microbiota across PCO1
(Fig. 4c). A two-way crossed permutational multivariate
analysis of variance (PERMANOVA) with specimen type
as a fixed factor and the children as a random factor
confirmed that the microbiota were significantly
Fig. 3 Alpha diversity in the microbiota of different specimen types. a OTU-level richness in different specimen types. b Simpson’s index of diversity in
different specimen types. Values approaching one indicate higher richness and more even community structure. Values approaching zero indicate
communities dominated by a small number of taxa. c Relative abundance of the most dominant OTU in different specimen types (Max. OTU relative
abundance). d Diversity in NP swabs from each diagnostic group. Diversity in NP swabs from control children was significantly lower than that
in children with CSLD (Dunn’s post hoc test, p < 0.0001); comparisons between other groups did not reach statistical significance after correcting for
multiple measures. NP NP swabs, OP OP swabs
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different between the OP and NP specimens (p =
0.0001, Pseudo-F 35.3, degrees of freedom (df ) 1), with
35.5 % of the total variation explained by differences
between the two specimen types. This variation was 2.3
times larger than the variation between children
(15.7 %; Table 3).
Comparison of Lavage-1 and Lavage-2 microbiota
There was no significant difference between the bacterial
loads in paired Lavage-1 and Lavage-2 specimens
(Mann-Whitney U test p = 0.39). Likewise, there was no
difference between the microbiota in Lavage-1 and
Lavage-2 (PERMANOVA p = 0.72, Pseudo-F = 0.8, df 1;
Table 3). Median Bray-Curtis similarity between paired
lavage specimens was 70.9 % (95 % CI 63.2–74.0), a level
comparable to that of the sequencing reproducibility
control (71.1 %; this control is described further in the
methods and Additional file 1). In a PCoA, the lavage
specimens were dispersed across PCO1 between the OP
and NP data points (Fig. 4a), suggesting similarity of the
lavage microbiota to both the OP and NP microbiota in
some children. The similarity percentages routine (SIM-
PER) in PRIMER identified three OTUs consistent with
Mitis Group Streptococci (including Streptococcus
pneumoniae), Haemophilus influenzae and Prevotella as
individually accounting for most variation between lav-
age specimens (16, 11 and 7 %, respectively). The rela-
tive abundance of these OTUs in lavage specimens was
significantly correlated with that in either the OP (Prevo-
tella OTU, Spearman rho = 0.68; p < 0.0001), the NP
(Mitis Group Streptococcus Spearman rho = 0.39; p =
0.001) or both upper airway specimens (H. influenzae,
Spearman rho = 0.5, p < 0.0001), suggesting similarity of
lavage microbiota to those in both the OP and NP.
Lavage microbiota were distinct from OP and NP
microbiota
PERMANOVA detected significant differences between
the microbiota in both the OP (p = 0.0001, Pseudo-F
12.2, df 1) and the NP (p = 0.0001; Pseudo-F 21.9; df 1)
when compared to Lavage-1; however, this difference
was more pronounced between NP and Lavage-1 spec-
imens, as indicated by a higher Pseudo-F value
(Table 3). Bray-Curtis similarity between paired OP
and Lavage-1 specimens was >50 % for 37/65 (57.8 %)
children, compared with only 5/65 (7.7 %) children
when NP and Lavage-1 microbiota were compared.
Two children had >50 % Bray-Curtis similarity
Table 2 OTUs detected at >50 % relative abundance in each specimen type
Specimen type OTU SILVA reference taxonomy BLASTn (% identity) Maximum relative abundance (%)
NP swabs OTU00003 Moraxella Moraxella catarrhalis (98 %) 99.8
OTU00002 Pasteurellaceae Haemophilus influenzae (99 %) 96.7
OTU00008 Staphylococcus Staphylococcus aureus (100 %) 96.4
OTU00012 Corynebacterium Corynebacterium propinquum (100 %) 98.1
OTU00001 Streptococcus Mitis Group Streptococci (99 %) 94.9
OTU00022 Moraxella Moraxella nonliquefaciens (99 %) 94.1
OTU00017 Enhydrobacter Moraxella lincolnii (98 %) 81.2
OTU00061 Unclassified Mycoplasma amphoriforme (99 %) 61.3
OTU00029 Flavobacteriaceae Ornithobacterium rhinotracheale (90 %) 54.7
OTU00060 Proteobacteria Unclassified 53.6
OP swabs OTU00006 Bacteroidetes Porphyromonas sp. (99 %) 62.5
Lavage-1 OTU00003 Moraxella Moraxella catarrhalis (98 %) 92.6
OTU00008 Staphylococcus Staphylococcus aureus (100 %) 83.8
OTU00002 Pasteurellaceae Haemophilus influenzae (99 %) 83.5
OTU00022 Moraxella Moraxella nonliquefaciens (99 %) 79.2
OTU00011 Neisseria Neisseria lactamica (99 %) 60.2
OTU00004 Prevotella Prevotella sp. (98 %) 51.9
Lavage-2 OTU00002 Pasteurellaceae Haemophilus influenzae (99 %) 99.7
OTU00003 Moraxella Moraxella catarrhalis (98 %) 87.7
OTU00001 Streptococcus Mitis Group Streptococci (99 %) 67.4
OTU00004 Prevotella Prevotella sp. (98 %) 51.2
BLASTn identities were selected based on 100 % coverage and >98 % identity score (% identity), except for OTU00029 which was not identified above 90 %
identity. This OTU was conditionally identified as Ornithobacterium rhinotracheale, but this taxonomy must be interpreted with caution. Bacterial load in specimens
dominated by the Enhydrobacter OTU at >50 % relative abundance was consistently >1 × 103 GE/μL extracted DNA (Additional file 1: Figure S5)
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Fig. 4 (See legend on next page.)
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between the Lavage-1 microbiota and that of the
paired OP and NP swabs, whereas for 25/65 (38 %)
children, the Lavage-1 microbiota were <50 % similar
to that in either of the paired OP or NP swabs.
Combining OP and NP data increased overall similarity
with the lavage microbiota, but significant differences
remained
We next combined the OP and NP data to determine
whether an upper airway sampling strategy that included
both sites concurrently would provide a more compre-
hensive representation of Lavage-1 microbiota. The
combined OP and NP data were significantly different to
Lavage-1 (PERMANOVA p = 0.0001; Pseudo-F 6.8, df 1);
however, the Pseudo-F statistic was 1.8 and 3.2 times
lower than comparisons of Lavage-1 with the OP or NP
microbiota, respectively (all df 1; Table 3). Furthermore,
the PERMANOVA components of variation showed that
differences in the microbiota among specimen types
contributed 25.3, 17.9 and 13.0 % of variation between
NP, OP and combined upper airway data, respectively,
when compared to Lavage-1. These findings indicate
that the combined OP and NP data provided a better
representation of Lavage-1 microbiota than analysis of
either upper airway site alone; however, significant dif-
ferences remained.
We then tested whether combined Lavage-1 and
Lavage-2 data would show higher similarity to the upper
airway microbiota than analysis of Lavage-1 alone. This
analysis was performed for the subset of 49 children
with paired Lavage-2 data. Inclusion of Lavage-2 data in-
creased the richness detected from the lower airways by
2–27 OTUs (median 8, 95 % CI 6–12) for 27/49 chil-
dren. Overall, Bray-Curtis similarity between the com-
bined OP and NP data (upper airway microbiota) and
the combined Lavage-1 and Lavage-2 data (lower airway
microbiota) was >50 % for 34/49 (69.4 %) children. A
PERMANOVA test showed higher similarity between
the upper and lower airway data after inclusion of
Lavage-2 (Pseudo-F 4.9, df 1; Table 3); however, signifi-
cant differences remained (PERMANOVA p = 0.0001)
with 12.1 % of the total variation explained by variation
among the upper and lower airway microbiota. Variation
in the microbiota due to differences between the
(See figure on previous page.)
Fig. 4 Lavage microbiota shows similarity to both OP and NP. Principal coordinate analysis (PCoA) demonstrating relationships between the
microbiota in different specimen types based on a Bray-Curtis similarity matrix derived from square root transformed OTU-level data. a The NP
and OP microbiota were distinct, whereas Lavage-1 and Lavage-2 specimens were dispersed between the OP and NP data points. Red circles = NP
swabs. Dark blue squares = OP swabs. Light blue triangles = Lavage-1. Mustard diamonds = Lavage-2. b Dispersion across the main axis (PCO1)
reflected differences in the relative abundance of the dominant OTU. The PCoA is identical to that in part A of this figure but has been coloured
to indicate the relative abundance of the dominant OTU. Dark blue triangles = dominant OTU at <50 % relative abundance. Light blue squares =
dominant OTU at 50–80 % relative abundance. Red circles = dominant OTU at >80 % relative abundance. c A vector plot visualising directional
effects of dominant OTUs (Table 2) in the different specimen types. Vectors show the Pearson rank correlation between each OTU and the
PCO axes. The vectors are labelled to indicate the BLAST identification of dominant OTUs. The Mitis Group Streptococci vector indicates a
single OTU that could not be identified to the species level. Mitis Group Streptococci include Streptococcus pneumoniae. Vectors are not
shown for Porphyromonas, Terrahaemophilus, and Gemella OTUs as they overlapped with Neisseria, Prevotella and Haemophilus haemolyticus,
respectively. Likewise, vectors are not shown for Granulicatella adiacens and Moraxella nonliquiefaciens as they overlapped with the Streptococcus mitis
and Moraxella lincolnii vectors, respectively
Table 3 Similarity of the upper and lower airway microbiota
Comparison Number of
children
Bray-Curtis
similarity
median
(95 % CI)
PERMANOVA
Variation between specimen types Variation between children Residual variation
p Pseudo-F (df) %CoV p Pseudo-F (df) %CoV %CoV
NP and OP 65 10.1 (8.2–12.6) 0.0001* 35.3 (1) 35.5 0.001* 1.2 (64) 15.7 48.8
Lavage-1 and Lavage-2 57 70.9 (63.2–74.0) 0.72 0.8 (1) n/a 0.0001* 6.01 (57) 61.4 38.6
NP and Lavage-1 65 25.6 (22.3–28.8) 0.0001* 21.9 (1) 25.3 0.0001* 1.9 (64) 30.1 44.6
OP and Lavage-1 65 54.5 (44.9–57.6) 0.0001* 12.2 (1) 17.9 0.0001* 2.7 (64) 39.2 42.9
Upper and Lavage-1 65 53.5 (48.4–56.7) 0.0001* 6.8 (1) 13.0 0.0001* 3.0 (64) 43.4 43.5
Upper and lower 49 55.5 (51.7–58.6) 0.0001* 4.9 (1) 12.1 0.0001* 3.2 (48) 45.1 42.8
The microbiota in paired Lavage-1 and Lavage-2 specimens showed high similarity, whereas the microbiota in paired OP and NP swabs were distinct. Lavage-1
microbiota was significantly different to the OP and NP microbiota. The highest similarity between the upper and lower airway data was obtained by combining
OP with NP data (to represent the upper airways) and Lavage-1 with Lavage-2 data (to represent the lower airways). All analyses were performed using a
Bray-Curtis similarity matrix based on square root transformed OTU-level data. CoV is the estimated components of variation and indicates the data variability due
to the specified factor. Comparisons were limited to the 73 children whose paired specimens each returned >1025 16S rRNA gene sequence reads (Fig. 1).
Lavage-2 data were only available for a subset of children
n/a not applicable
*Indicates significant results
Marsh et al. Microbiome  (2016) 4:37 Page 8 of 18
children explained 45.1 % of the total variance (p =
0.0001; Pseudo-F 3.2, df 48), while 42.8 % of the data
variability remained unexplained.
Significant differences detected in the PERMANOVA
test likely reflect a subset of children with low similarity
observed between the lower and upper airway data. This
was evident in hierarchical group average cluster analysis
that showed paired upper and lower airway data from
33/49 (67.3 %) children clustered together with signifi-
cant similarity, whereas no significant similarity was de-
tected for 16/49 (32.7 %) children (Fig. 5). As a
comparison, paired OP and Lavage-1 specimens from
only 27/65 (41.5 %) children clustered together in hier-
archical cluster analysis (Additional file 1: Figure S4).
Clustering of paired upper and lower airway data was
not associated with recent antibiotic use or low bacterial
load in any of the specimens (all comparisons Mann-
Whitney U test p > 0.05); 7/16 (44 %) children with low
similarity between paired upper and lower airway data
and 16/33 (49 %) children with high similarity had high
bacterial load in all specimens. Low similarity between
the upper and lower airway microbiota was also unrelated
to the diagnostic group; the lower and upper airway
microbiota from 11/31 (35 %) children with CSLD, 4/13
(31 %) children with PBB and 1/5 (20 %) control children
failed to cluster together. Collectively, these data indicate
that the highest similarity between the microbiota in the
different airway sites was obtained when the upper (com-
bined NP and OP swabs) and lower airway (combined
Lavage-1 and Lavage-2) data were compared; however,
Fig. 5 Paired specimens from 65 % of children were more similar to each other than to specimens from other children. Hierarchical group average
cluster analysis based on Bray-Curtis similarity matrix derived from square root transformed OTU-level data. Forty-nine children with sequence data for
upper airway (combined NP and OP) and lower airway (combined Lavage-1 and Lavage-2) microbiota were included in the cluster analysis. Coloured
symbols at the right of the figure indicate paired upper and lower airway data from individual children. A similarity profile permutation test was used
to identify clusters with significant similarity (red dashed branches)
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significant overall differences remained due to low similar-
ity between paired data from a subset of children.
Microbiota in lower and upper airways discriminated
clinically defined groups
As paired upper and lower airway data from 67.3 % chil-
dren clustered together despite the overall significant
difference in the microbiota, we next tested whether dis-
crimination of disease groups based on analysis of lower
airway microbiota would have been detected if only the
upper airway data were analysed. This was done by test-
ing for differences in the lower airway microbiota related
to each disease group and then determining if any
observed discrimination was reproduced in the analysis
of the upper airway microbiota.
PERMANOVA detected significant differences in the
lower airway microbiota among the disease groups (p =
0.0001; Pseudo-F 2.46; df 2), with 29.2 % of the total
variation in the microbiota explained by differences
among diagnostic groups. Clustering of data points from
each diagnostic group was suggested in the PCoA
(Fig. 6a); however, there was an overlap between the
groups with only 26.4 % of the total variation explained
by PCO1 and PCO2. Canonical analysis of principal co-
ordinates (CAP) was then used to determine if other
axes would better discriminate the microbiota based on
Fig. 6 Significant discrimination of microbiota in different diagnostic groups detected for both the lower and upper airway data. Differences in
the microbiota from children with CSLD (red triangles) and PBB (light blue circles) and control children (dark blue squares) were evident in principal
coordinate analysis of the lower (a) and upper (c) airway data. In the lower airway plots, each data point represents the combined Lavage-1 and
Lavage-2 data from a single child. Likewise, in the upper airway plots, each data point represents the combined NP and OP data from a single
child. Canonical analysis of principal coordinates (CAP) from the lower (b) and upper (d) airway data discriminated the diagnostic groups. Each
CAP included 49 children. CAP eigenvalues were all >0.8. The misclassification error was 26.5 and 12.2 % for the lower and upper airway data,
respectively. CAP of lower and upper airway specimens were optimised with 26/49 and 18/49 PCO axes, respectively
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the a priori defined diagnostic groups. The CAP analysis
detected significant differences between the lower airway
microbiota based on the diagnostic group (eigenvalues
CAP1 0.86, CAP2 0.80; misclassification rate 26.5 %;
trace statistic p = 0.02) with distinct separation of the
groups across the CAP axes (Fig. 6b).
This group-specific discrimination was reproduced in
the analysis of the upper airway microbiota (PERMA-
NOVA p = 0.0001; Pseudo-F 3.59, df 2). Dispersion of
the upper airway data in PCoA was different to that of
the lower airways (Figs. 6a, c), reflecting underlying dif-
ferences in the diversity between the two anatomic sites.
As with the lower airway data, there was some overlap
between data points for each diagnostic group in the
PCoA that was resolved by CAP analysis (eigenvalues
CAP1 0.89, CAP2 0.85; misclassification rate 12.2 %;
trace statistic p = 0.0001) with distinct separation of the
groups across the CAP axes (Fig. 6d). These data indi-
cate that differences between each diagnostic group were
detected regardless of whether the lower or upper airway
microbiota data were analysed.
SIMPER analysis was then performed to identify
OTUs that contributed most to the significant dissimi-
larity in the microbiota between the diagnostic groups.
SIMPER analyses were limited to comparisons of chil-
dren with CSLD or PBB, as paired upper and lower air-
way data were available for only five control children
(too few to allow robust analysis). For SIMPER analysis
comparing the microbiota in children with CSLD or
PBB, the top 10 OTUs contributed 30 and 26 % of the
variation in the lower and upper airway data, respect-
ively. Seven of the 10 OTUs contributing most to dis-
crimination of the diagnostic groups based on analysis of
lower airway data also discriminated the groups in the
analysis of the upper airway data (Table 4). Furthermore,
the top four OTUs contributing to discrimination of the
diagnostic groups (consistent with Moraxella catarrha-
lis, H. influenzae, Prevotella sp. and Mitis Group
Streptococci) were the same in analysis of the lower and
upper airway data (Table 4); these four OTUs collect-
ively explained 17.8 % the variation in the lower airway
microbiota and 14.9 % of the variation in the upper air-
way data between the diagnostic groups.
We then visualised relationships between OTUs
identified by SIMPER analysis and the CAP axes. This
was done using a Spearman rank correlation between
each OTU and the CAP axes [27] with results repre-
sented as a vector plot (Fig. 7). For the lower airway
data (Fig. 7a), the CAP2 axis best discriminated the
CSLD and PBB groups. Dispersion across CAP2 was
associated with OTUs consistent with Mitis Group
Streptococci, H. influenzae, a Porphyromonas sp. and
Prevotella melaninogenica (discriminating the CSLD
group), and M. catarrhalis, a Neisseria sp., a second
Prevotella sp. and Haemophilus haemolyticus (discrim-
inating the PBB group).
Similar findings were observed in the analysis of the
upper airway data, except that the CSLD and PBB
groups were discriminated across the CAP1 axis (Fig. 7b).
As with the lower airway data, discrimination of the
groups was associated with OTUs consistent with Mitis
Group Streptococci, H. influenzae, a Porphyromonas sp.
and Moraxella lincolnii (discriminating the CSLD
group), and M. catarrhalis, a Neisseria sp., 2 Prevotella
sp., H. haemolyticus and Staphylococcus aureus (discrim-
inating the PBB group). The OTU consistent with C.
propinquum contributed to separation across CAP2, but
not CAP1 (Fig. 7b). Collectively, these data show that
the observed discrimination of the CSLD and PBB
groups was associated with similar OTUs in analysis of
both the lower and upper airway data.
Table 4 Results of SIMPER analysis comparing the microbiota in
children with PBB and CSLD
Site OTU BLASTn (% identity)
Lower airway data Otu00003 Moraxella catarrhalis (98)
Otu00002 Haemophilus influenzae (99)
Otu00004 Prevotella sp. (98)
Otu00001 Mitis Group Streptococci (99)
Otu00011 Neisseria lactamica (99)
Otu00010 Neisseria sp. (99)
Otu00005 Haemophilus haemolyticus (99)
Otu00006 Porphyromonas sp. (99)
Otu00009 Prevotella melaninogenica (100)
Otu00030 Leptotrichia sp.(88)*
Upper Airway Data Otu00003 Moraxella catarrhalis (98)
Otu00002 Haemophilus influenzae (99)
Otu00001 Mitis Group Streptococci (99)
Otu00004 Prevotella sp. (98)
Otu000012 Corynebacterium propinquum (100)
Otu00005 Haemophilus haemolyticus (99)
Otu00008 Staphylococcus aureus (100)
Otu00006 Porphyromonas sp. (99)
Otu000010 Neisseria sp. (99)
Otu000017 Moraxella lincolnii (98)
SIMPER analysis was performed to determine the OTUs that contributed most
to the observed significant dissimilarity in the microbiota between diagnostic
groups. Results are shown for the 10 OTUs in the lower and upper airway data
that contributed most to the differences between children with CSLD and PBB.
In comparison of children with CSLD or PBB, these OTUs contributed 30 and
26 % of the observed variation in the lower and upper airway microbiota,
respectively. Comparisons with control children were not done as too few
control children (n = 5) had paired upper and lower airway data to allow
robust assessment of explanatory variables. OTUs are listed in a decreasing
order of variation explained. BLASTn identities were selected based on 100 %
coverage and >98 % identity score (% identity). OTU00030 was identified by
BLASTn as Leptotrichia (*), but with only 88 % identity
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Discussion
We have shown that the combined OP and NP micro-
biota provided a better representation of BAL microbiota
for most children in our study (67.3 %) than the analysis
of the microbiota in either the upper airway site alone;
however, low similarity between the paired upper and
lower airway microbiota was detected for 32.7 % of the
children. Despite low similarity in some children, a CAP
analysis showed that a non-invasive sampling strategy
that combined OP and NP swabs discriminated clinically
Fig. 7 Analysis of OTUs contributing to discrimination of clinically defined groups based on analysis of the lower or upper airway microbiota.
SIMPER analysis was used to identify the top 10 OTUs contributing to discrimination of the CSLD and PBB groups. These OTUs were visualised on
the CAP ordination with vectors whose length and direction reflected the Spearman rank correlations of these OTUs with the CAP axes. For the
lower airway data (a), OTU vectors consistent with a Prevotella sp. and a Leptotrichia sp. are not shown as they overlapped with the M. catarrhalis
and the Neisseria sp. vectors, respectively. For the upper airway data (b), the OTU vector consistent with M. lincolnii is not shown as it overlapped
with the Porphyromonas sp. vector
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defined groups of children as well as the microbiota in
invasive lavage specimens. This observation was sup-
ported by results of a SIMPER analysis that showed
seven of the top 10 OTUs contributing to discrimination
of the lower airway data from children with CSLD and
PBB and also contributed to discrimination of clinical
groups in analysis of the upper airway data. Collectively,
these results suggest that combined NP and OP sam-
pling provided an imperfect, but reliable, measure of air-
way microbiota for most children in this study. Based on
these results, we recommend that both OP and NP spec-
imens are included when measures of upper airway
microbiota are used to study lower airway disease in
young children who do not expectorate.
Our results showing combined OP and NP provided
the best representation of BAL microbiota likely re-
flects the importance of microbes in the nasopharynx
to the lower airway infection in young children. Studies
of adults and older children have reported high similar-
ity between the OP and the lower airway microbiota
and concluded that the lung microbiota develops from
microaspiration of oral flora [1, 13]. Seeding of the
lower airways by NP microbiota during episodes of rhi-
norrhoea has been suggested [28], but there have been
limited data to date to support this hypothesis. Epi-
sodes of rhinorrhoea associated with upper respiratory
tract infection are common in young children [29, 30].
Furthermore, the nasopharynx is an important reser-
voir of respiratory pathogens in paediatric populations
[14, 16, 31], with NP pathogen carriage associated with
the increased risk of lower airway infection [32]. Sev-
eral studies have reported associations between NP
microbiota and lower airway diseases including pneu-
monia [17], bronchiolitis [33] and asthma [18]. A longi-
tudinal study of NP aspirates from 234 children under
1 year of age identified the NP microbiota as a deter-
minant for infection spreading to the lower airways
[18]. Culture-based studies have also shown high con-
cordance between the presence of pathogenic species
and strains in the nasopharynx and BAL of young chil-
dren with bronchiectasis [16]. While these findings
support a role for the NP microbiota seeding the lower
airways of young children, it is unclear if this only oc-
curs during episodes of rhinorrhoea or is related to
other mechanisms. Our data highlight the need for fur-
ther research to understand mechanisms of seeding the
lower airways by NP microbiota, particularly in paediat-
ric populations.
The low similarity between the paired upper and lower
airway data in 32.7 % of the children was unrelated to
recent antibiotic treatment, low bacterial load or diag-
nostic group. Earlier studies also detected subsets of in-
dividuals with dissimilarity between the upper and lower
airway specimens. Bassis et al. [1] compared oral wash
and BAL microbiota in 28 healthy adults and found that
although the microbiota in the different specimen types
showed significant overlap, the microbiota in paired
specimens from 57 % of the study cohort were dissimi-
lar. Likewise, Zemanick et al. [8] reported overlap be-
tween the microbiota in OP swabs and sputum
specimens from older children and young adults with
cystic fibrosis, with significant divergence between oral
and sputum microbiota in a subset of the cohort related
to increased relative abundance of potentially pathogenic
genera in sputum specimens. The reasons for the dis-
similarity between the paired upper and lower airway
specimens in our study are unclear but may indicate ei-
ther a role for other upper airway bacterial reservoirs
in seeding the lower airways (for example, the sinuses
[4, 34, 35]) or lower airway environmental pressures
that select for specific microbiota [1, 8].
Our results highlight the importance of considering
the generalizability of airway microbiota data. Our ob-
servations are specific to a cohort of young children
(median age 2.2 years) with PBB, CSLD or no lung dis-
ease. In contrast, findings from other studies have been
specific to populations of healthy adults [1]; older chil-
dren, adolescents and adults with cystic fibrosis [8, 10, 13];
and patients with end-stage respiratory disease [9, 11]. At
the extremes of this spectrum, studies of healthy adults
have demonstrated correlation between the OP and the
lower airway microbiota [1], whereas studies of end-stage
respiratory disease have demonstrated divergence of the
microbiota from the lung and OP specimens [9, 11]. Our
finding that lavage microbiota showed similarity to both
OP and NP microbiota may not be generalizable to
other paediatric or adult populations or to children
with end-stage respiratory disease; however, this limita-
tion is common to all studies of respiratory microbiota
in defined populations. Understanding the similarity
and divergence of the microbiota across the airways in
populations of different age and clinical presentation
remains an important area for future research.
The clinical implications of our findings are unclear.
The CAP analysis suggests lower and/or combined OP
and NP microbiota profiles may differentiate CSLD and
PBB. The OTUs discriminating the CSLD and PBB
groups were consistent with the taxa previously reported
in the NP of young Dutch children [14] and in the NP,
OP and BAL of healthy adults [1]. Biesbroek et al. [14]
reported fewer respiratory infections in children with
NP colonisation by Moraxella, Corynebacterium and
Dolosigranulum species compared to children colonised
by Streptococcus and Haemophilus species. In our study,
OTUs consistent with Mitis Group Streptococci and H.
influenzae were associated with children with CSLD,
whereas M. catarrhalis was associated with PBB. Bassis
et al. [1] reported enrichment of Prevotella sp. in the
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lung, whereas in our study, Prevotella in the upper air-
way data was associated with the PBB group.
Our results must, however, be considered within the
limitations of our study design (a cross-sectional analysis
with imbalances between the clinically defined groups).
Although the study design was suitable for assessing the
similarity of the lower and upper airway microbiota, po-
tential confounding factors limit clinical inference. For
example, 83 % of the children with CSLD were Indigen-
ous Australians compared with only 7 % of children
with PBB and none of the controls. No studies have
compared the upper or lower airway microbiota in In-
digenous and non-Indigenous children; however, cul-
ture and PCR-based studies have reported significant
differences in the multiplicity and density of potential
respiratory pathogens colonising the nasopharynx of
Indigenous compared to non-Indigenous Australian
children [36, 37]. Furthermore, an earlier study com-
paring the microbiota in non-Indigenous Australian
children with PBB and CSLD did not detect disease-
associated microbiota and instead reported a core BAL
microbiota common to both disease groups [5]. Thus,
it is unclear whether the discrimination observed in our
study indicates disease-specific microbiota profiles or
underlying population-level differences. Likewise, we
cannot exclude potential confounding due to antibiotic
treatment, as 65 % of the children with CSLD had re-
cently received antibiotics compared with ~20 % of
controls and children with PBB. Further investigation
to confirm whether upper and/or lower airway micro-
biota profiles differentiate CSLD and PBB is warranted
but was beyond the scope of the current study. Further
study is also needed to understand whether airway
microbiota in Indigenous Australian children is differ-
ent to that of non-Indigenous children and whether
such differences may relate to the disproportionately
high rates of CSLD in Indigenous children [38].
Age-related factors may also confound analysis of
disease-specific differences in airway microbiota. Longi-
tudinal studies have reported age-related changes in NP
microbiota [14], whereas we did not detect associations
between age and bacterial load or diversity in any of the
specimen types. Cross-sectional analysis of age-related
changes in the airway microbiota of children with
chronic lung diseases may also be confounded by differ-
ences in the age at disease-onset, duration of disease,
and disease severity. Such data were not available for in-
clusion in our analysis.
Consistent with earlier reports [17, 39, 40], a high pro-
portion (31 %) of DNA extracts in our study had bacter-
ial loads below that recommended for 16S rRNA gene
sequencing [24, 25]. A significant role for contaminant
OTUs in sequence data from low bacterial load speci-
mens was recently recognised [24]. The method we used
to exclude contaminant OTUs was reported previously
for analysis of low bacterial load upper airway and mid-
dle ear specimens from otitis media patients [26]. While
this method proved useful, allowing successful character-
isation of the microbiota in 77/94 specimens with low to
very low bacterial load, it remains possible that further
refinement of the current methods may improve detec-
tion and eradication of contaminant OTUs. Refinement
of such algorithms was beyond the scope of the current
study but should remain an area of active research.
Low bacterial load in our specimens is unlikely to re-
flect a sampling bias, as all specimens were collected
using the same standardised protocol while children
were under general anaesthesia. Furthermore, low bac-
terial load was consistently detected across the NP and
lavage specimens from 15/78 children in our study, sug-
gesting it may be a feature of the airways in specific chil-
dren. The clinical significance of this observation is
unclear; however, low bacterial load in airway specimens
has been associated with better clinical outcomes in pa-
tients with respiratory infections [6, 41]. Alternative ex-
traction methods may also increase bacterial DNA yield
from low biomass specimens [25] and, thus, improve
microbiomic characterisation of paediatric airway speci-
mens [42]. This may be especially important if NP swabs
are included in upper airway sampling strategies.
Several technical limitations should also be consid-
ered when interpreting results from this study. All
specimens were placed in skim milk tryptone glucose
glycerol broth (STGGB )media prior to long-term stor-
age at −80 °C. STGGB is a preservative media opti-
mised for recovery of respiratory pathogens [43] and is
widely used in NP carriage studies [44]. While it is pos-
sible that storage in STGGB may have permitted over-
growth of some taxa, we believe this is unlikely as the
specimens were kept on ice after collection and were
stored at −80 °C within 2 h of collection. We also can-
not exclude potential contamination from residual bac-
terial DNA in the bronchoscopes as instrument
background controls were not collected.
Conclusions
We have shown that for most children in our study, an
upper airway sampling strategy that combined OP and
NP microbiota provided better representation of BAL
microbiota than analysis of either upper airway site
alone. Our data suggest that the lower and upper airway
microbiota profiles may differentiate children with CSLD
or PBB; however, further testing is needed to confirm
this observation as our study was not optimally designed
for clinical inference. We conclude that although upper
airway sampling provided an imperfect representation of
the lower airway microbiota, it could be used as a reli-
able measure of airway microbiota for most children in
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this study. Sampling strategies that include both OP and
NP specimens are recommended when non-invasive
upper airway sampling is needed to assess airway micro-
biota in young children who do not expectorate.
Methods
This study was approved by the Human Research Ethics
Committee (HREC) of the Northern Territory Depart-
ment of Health and Menzies School of Health Re-
search, Darwin (HREC 07/63 and 09/02), and the Royal
Children’s Hospital, Brisbane (HREC 2003/017 and
200800064). Written informed consent was obtained
from the parent/carer of each child.
Clinical definitions
PBB was clinically defined based on the presence of a
wet cough for >4 weeks, the absence of specific causal
indicators for cough (e.g., failure to thrive, chest wall de-
formity) and resolution of cough within 2 weeks of com-
mencing appropriate antibiotic therapy [45]. CSLD was
clinically defined based on the presence of a wet pro-
ductive cough for >8 weeks, with a clinical profile of
bronchiectasis without cHRCT findings (either because
cHRCT was not undertaken or did not fulfil radiological
criteria) [46]. Bronchiectasis diagnosed by cHRCT was
based on an inside bronchial diameter-to-adjacent artery
ratio >0.8 [47]. None of the children with bronchiectasis
had cystic fibrosis.
Study cohort and specimens
The study cohort was a subset of children <10 years of
age sequentially enrolled in either (i) an observational
study of paediatric CSLD at Royal Darwin Hospital,
Darwin, Australia, between October 2011–October 2012
or (ii) an observational study of children undergoing bron-
choscopy at the Royal Children’s Hospital, Brisbane,
Australia, between February 2011 and November 2012
[48, 49]. Children (<10 years of age) undergoing flexible
bronchoscopy for a clinical indication, excluding cystic fi-
brosis, were eligible for inclusion in the Brisbane-based
study [49]. Children undergoing cHRCT and flexible bron-
choscopy for investigation of chronic cough and suspected
bronchiectasis were eligible for the Darwin-based study
[48]. The CSLD cohort included all children prospectively
recruited to the Darwin-based study and five randomly se-
lected children from the Brisbane-based study. The PBB
and control cohorts included all children with these
diagnoses prospectively recruited to the Brisbane-based
study who had sufficient specimens stored for bacterial
analyses (28/30 children with PBB and 10/12 disease
controls). The control children had undergone bron-
choscopy for assessment of other clinical presentations
(e.g. stridor, recurrent croup, unexplained dyspnea) as-
sociated with underlying diagnoses of tracheomalacia
(n = 6), laryngomalacia, and bronchomalacia (n = 2),
granulation on the vocal cords (n = 1) and an absent
cardiac segment (n = 1).
An OP swab, NP swab and two sequential BAL speci-
mens were collected while the children were under gen-
eral anaesthesia. Identical specimen collection protocols
were used for the Darwin- and Brisbane-based studies
[48, 49]. The OP and NP swabs were collected immedi-
ately prior to insertion of the bronchoscope. The NP
swabs were collected by placing a rayon-tipped swab
into the nasopharynx via a single nostril; the swab was
rotated for 2–3 seconds before being withdrawn and
placed in a tube containing 1 mL STGGB. The OP
swabs were collected by swabbing the anterior and pos-
terior pillars then placed in 1 mL of STGGB. Bronchos-
copy with collection of BAL was performed as per the
European Respiratory Society guidelines [50]. The BAL
were collected using two volumes of sterile normal sa-
line (1 mL/kg to a maximum of 10 mL for the first vol-
ume, Lavage-1; and 2 mL/kg to a maximum of 20 mL
for the second volume, Lavage-2) which was instilled
into the lobe and suctioned immediately into a mucus
trap. Lavage-1 sampled the most affected lobe (as deter-
mined by cHRCT) or the right middle lobe if cHRCT re-
sults were not available. Lavage-2 was collected from the
same lobe as Lavage-1. The aliquots of Lavage-l and
Lavage-2 were diluted in equivalent volumes of 2× con-
centrated STGGB for bacterial analyses. All specimens
were transported to the laboratory on ice bricks for pro-
cessing and storage within 2 hours, with all specimens in
STGGB stored at −80 °C prior to bacterial analyses.
Bacterial analyses
Bacterial analyses were performed using DNA extracted
from 200 μL of swab media (OP and NP swabs) and
400 μL of BAL in STGGB (equivalent to 200 μL of neat
BAL). DNA extraction was done using QIAamp columns
(QIAgen) with bead beating pre-treatment as detailed in
Additional file 1. A dedicated DNA aliquot was used to
determine the total bacterial load in each extract. The
bacterial load was estimated using qPCR targeting the
16S rRNA gene [23], as described previously [22]. Briefly,
each 10 μL qPCR reaction included 1× SensiMix™ SYBR®
reagent (Bioline), 300 nM of each primer (forward primer:
5′- TCCTACGGGAGGCAGCAGT -3′; reverse primer:
5′- GGACTACCAGGGTATCTAATCCTGTT -3′) and
1 μL of template DNA. The reaction conditions were an
initial hold at 50 °C for 2 min followed by incubation at
95 °C for 10 min then 35 cycles of 95 °C for 15 s, 58 °C for
15 s and 72 °C for 45 s. Melt-curve analysis was then done
between 80 and 90 °C with 0.1 °C steps. Low bacterial load
was defined as <103 GE/μL extracted DNA, as this level
was recommended previously for 16S rRNA gene sequen-
cing analyses [24, 25].
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Sequencing of the 16S rRNA gene V1-3 regions was
performed using a Roche 454 GS FLX Titanium platform
as detailed in Additional file 1. Four DNA extraction nega-
tive controls and two aliquots of a reproducibility control
were also sequenced. The reproducibility control was used
to measure variation between sequencing batches. It con-
tained DNA extracted from a pool of five OP swabs that
were all taken from an adult volunteer. DNA was ex-
tracted from the pooled OP swabs then aliquoted and
stored at −80 °C prior to sequencing. Results for the nega-
tive and reproducibility controls are detailed in Additional
file 1. Raw sequence data are available upon request and
subject to permission from the relevant Human Research
Ethics Committees.
Quality filtering of sequence data was done using
mothur (version 1.33.3) [51] according to the 454-SOP
[52, 53] with the following modifications: the sff.multiple
command was used to combine data from multiple sff
files; sequences with one or more mismatches in the bar-
code were excluded. OTUs were defined based on 97 %
sequence similarity and taxonomic classifications were
assigned using the SILVA reference alignment (release
102) [54]. Where reference to the SILVA alignment did
not identify OTUs beyond the family level, BLASTn [55]
was used to assign taxonomy based on 100 % coverage
and >98 % identity. Additional filtering was performed
to exclude probable contaminant OTUs and sequencing
errors (referred to collectively as probable contaminant
OTUs) that arise during amplification of specimens with
low bacterial load. This was done as earlier studies have
demonstrated an inverse relationship between bacterial
load and detection of spurious OTUs [24, 26]. Probable
contaminant OTUs arising from sequencing of specimens
with low bacterial biomass and contaminants detected in
negative controls were identified and excluded from fur-
ther analysis as described in Additional file 1. A complete
list of all OTUs excluded from downstream analyses is
presented in Additional file 1: Table S1. Following exclu-
sion of contaminant OTUs, subsampling to a depth of
1025 reads was performed based on review of rarefaction
curves and Good’s coverage. Specimens with fewer than
1025 reads were excluded from further analysis [24, 26].
Statistical analyses
Biostatistical analyses were performed using Stata/IC ver-
sion 14.0 (StataCorp LP, USA). All tests were two-tailed;
significant results were indicated by a p value of <0.05 un-
less otherwise stated. Median with binomial-based 95 %
CI was used to describe data that were not normally dis-
tributed. The non-parametric Mann-Whitney U test was
used to test for significant differences between two groups.
Comparison of multiple groups was done using a non-
parametric Kruskal-Wallis test followed by a post hoc
Dunn’s test with Bonferroni correction for pairwise
comparisons. Statistical dependence between continuous
variables was determined using a Spearman’s rank correl-
ation. Box and whisker plots were generated to show the
interquartile range (IQR; boxes), median (line within the
box), upper and lower adjacent values (whiskers) and
outliers (dots). Graphical figures were prepared with
Stata/IC or R version 3.2.3 [56] with the ggplot2 [57]
and beeswarm [58] packages.
Analyses of alpha and beta diversity in the microbiota
were performed using PRIMER (version 6.1.15) [27, 59].
Simpson’s index of diversity (1-D) was used to assess the
diversity of the bacterial community structures; this
measure takes OTU richness and relative abundance
into account. Beta diversity was assessed using a Bray-
Curtis similarity matrix based on square root trans-
formed OTU-level data. The SIMPER routine was used
to identify OTUs contributing most to variation between
specimens and diagnostic groups. Hierarchical group
average cluster analysis was performed with similarity
profile permutation test to determine if paired speci-
mens clustered together with significant similarity. Simi-
larity between the microbiota in different specimens was
visualised using unconstrained principal coordinate ana-
lysis. PERMANOVA was used to test for significant dif-
ferences between the microbiota in different specimen
types. The PERMANOVA was done using a crossed-
design with specimen type designated as a fixed factor
and child designated as a random factor. The Type III
sums of squares method was used with permutation of
residuals under a reduced model and 9999 permitted
permutations. One-way PERMANOVA to test for sig-
nificant differences between the microbiota in each diag-
nostic group was performed using the Type III sums of
squares method with unrestricted permutation of raw
data. Where PERMANOVA detected significant differ-
ences in the microbiota between clinically defined
groups, a discriminant canonical analysis of principal co-
ordinates (CAP) was used to identify principal coordi-
nates that best explained variation in the microbiota. In
contrast to principal coordinate analysis which identifies
axes that best explain the overall variability in the data,
CAP is a constrained test that identifies principal coordi-
nates that best discriminate a priori defined groups [27].
The CAP analysis was done to identify the principal co-
ordinates with the lowest misclassification error (equiva-
lent to those that best discriminated the groups). CAP
diagnostics were performed using a leave-one-out alloca-
tion procedure to identify the number of axes (m) re-
quired to minimise the misclassification error. The CAP
eigenvalues of the squared canonical correlations were
used to indicate the ability of the corresponding axes to
separate the a priori defined groups. The significance of
differences detected by CAP analysis was determined
using the permutation-based trace statistic [27].
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Additional file
Additional file 1: Supplementary materials. Figure S1: Relative
abundance of contaminant OTUs in different specimen types. Figure S2:
Principal coordinate analysis demonstrating that specimens with low
bacterial load did not cluster discretely from those with >103 GE/μL
extracted DNA. Figure S3: Bacterial diversity in each specimen type
separated by diagnostic group. Figure S4: Similarity of OP swab and
Lavage-1 microbiota. Figure S5: Scatterplots representative of relationships
observed for potential contaminant taxa in clinical specimens. Table S1:
Probable contaminant OTUs removed prior to downstream analyses.
(DOCX 939 kb)
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